RUNX1/miR-582-5p Pathway Regulates the Tumor Progression in Clear Cell Renal Cell Carcinoma by Targeting COL5A1

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNAs (miRNAs) are implicated in clear cell renal cell carcinoma (ccRCC) progression.
• The precise molecular mechanisms of miRNAs in ccRCC remain incompletely understood.

Purpose of the Study:

• To elucidate the role and regulatory mechanism of miR-582-5p in ccRCC.
• To investigate the potential of miR-582-5p as a biomarker and therapeutic target in ccRCC.

Main Methods:

• Quantitative reverse transcription polymerase chain reaction (qRT-PCR) to assess miR-582-5p expression.
• In vivo and in vitro experiments to evaluate tumor growth inhibition.
• Database prediction and chromatin immunoprecipitation to identify regulatory factors.
• Rescue experiments to validate regulatory relationships.

Main Results:

• miR-582-5p was found to be downregulated in ccRCC tissues and cell lines.
• Lower miR-582-5p expression correlated with advanced tumor stage and metastasis.
• miR-582-5p inhibited ccRCC tumor growth and invasion by suppressing COL5A1.
• RUNX1 was identified as a negative regulator of miR-582-5p.

Conclusions:

• miR-582-5p acts as a tumor suppressor in ccRCC by targeting COL5A1.
• The RUNX1/miR-582-5p/COL5A1 axis represents a potential therapeutic strategy for ccRCC.
• miR-582-5p may serve as a valuable biomarker for ccRCC prognosis.